WO2020197346A3 - 녹차 유래 성분을 함유하는 바이러스 백신용 면역증강제 조성물 - Google Patents
녹차 유래 성분을 함유하는 바이러스 백신용 면역증강제 조성물 Download PDFInfo
- Publication number
- WO2020197346A3 WO2020197346A3 PCT/KR2020/004289 KR2020004289W WO2020197346A3 WO 2020197346 A3 WO2020197346 A3 WO 2020197346A3 KR 2020004289 W KR2020004289 W KR 2020004289W WO 2020197346 A3 WO2020197346 A3 WO 2020197346A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- green tea
- composition containing
- virus vaccine
- adjuvant composition
- vaccine adjuvant
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000012646 vaccine adjuvant Substances 0.000 title abstract 2
- 229940124931 vaccine adjuvant Drugs 0.000 title abstract 2
- 244000269722 Thea sinensis Species 0.000 title 1
- 235000009569 green tea Nutrition 0.000 title 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 3
- 229940030275 epigallocatechin gallate Drugs 0.000 abstract 3
- 239000002671 adjuvant Substances 0.000 abstract 2
- 229940094952 green tea extract Drugs 0.000 abstract 2
- 235000020688 green tea extract Nutrition 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
본 발명은 에피갈로카테킨 갈레이트(epigallocatechin gallate; EGCG) 또는 녹차 추출물을 유효성분으로 함유하는 바이러스 백신용 면역증강제 조성물에 관한 것으로, 본 발명의 면역증강제는 다양한 바이러스에 대한 면역반응에서 우수한 면역촉진 효능을 발휘할 뿐 아니라, 독성이 거의 없어 안전성이 매우 우수하다. 또한, 본 발명의 녹차 추출물 또는 EGCG로 이루어지는 면역증강제는 Alum과 병용사용하였을 때 백신의 면역반응을 더욱 강력하게 향상시킬 수 있다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190035847A KR20200114310A (ko) | 2019-03-28 | 2019-03-28 | 녹차 유래 성분을 함유하는 바이러스 백신용 면역증강제 조성물 |
KR10-2019-0035847 | 2019-03-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2020197346A2 WO2020197346A2 (ko) | 2020-10-01 |
WO2020197346A3 true WO2020197346A3 (ko) | 2020-11-19 |
Family
ID=72610638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/004289 WO2020197346A2 (ko) | 2019-03-28 | 2020-03-30 | 녹차 유래 성분을 함유하는 바이러스 백신용 면역증강제 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (2) | KR20200114310A (ko) |
WO (1) | WO2020197346A2 (ko) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110094935A (ko) * | 2010-02-18 | 2011-08-24 | 재단법인 하동녹차연구소 | 녹차를 유효성분으로 함유하는 조류 인플루엔자에 대한 항바이러스제 |
KR20160147234A (ko) * | 2015-06-11 | 2016-12-22 | 연세대학교 산학협력단 | 녹차 추출물에 의해 불활화된 바이러스를 포함하는 백신 및 그의 제조방법 |
JP2018065825A (ja) * | 2011-06-24 | 2018-04-26 | エピットジェネシス・インコーポレーテッド | 抗原特異的免疫モジュレーターとして選択担体、ビタミン、タンニンおよびフラボノイドの組み合わせを含有する医薬組成物 |
-
2019
- 2019-03-28 KR KR1020190035847A patent/KR20200114310A/ko not_active Application Discontinuation
-
2020
- 2020-03-30 WO PCT/KR2020/004289 patent/WO2020197346A2/ko active Application Filing
-
2022
- 2022-02-03 KR KR1020220014471A patent/KR102429564B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110094935A (ko) * | 2010-02-18 | 2011-08-24 | 재단법인 하동녹차연구소 | 녹차를 유효성분으로 함유하는 조류 인플루엔자에 대한 항바이러스제 |
JP2018065825A (ja) * | 2011-06-24 | 2018-04-26 | エピットジェネシス・インコーポレーテッド | 抗原特異的免疫モジュレーターとして選択担体、ビタミン、タンニンおよびフラボノイドの組み合わせを含有する医薬組成物 |
KR20160147234A (ko) * | 2015-06-11 | 2016-12-22 | 연세대학교 산학협력단 | 녹차 추출물에 의해 불활화된 바이러스를 포함하는 백신 및 그의 제조방법 |
Non-Patent Citations (2)
Title |
---|
AL-ZUBAIDY, I. A.: "An attempt to prepare an effective killed vaccine with an adjuvant (green tea extract) against Salmonella typhimurium", JOURNAL OF ENTOMOLOGY AND ZOOLOGY STUDIES, vol. 5, no. 4, 2017, pages 1375 - 1380, XP055753385 * |
YUN H. LEE, YO H. JANG, YOUNG H. BYUN, YUCHEOL CHEONG, PAUL KIM, YOUNG J. LEE, YOON J. LEE, JE M. SUNG, AHYUN SON, HYE M. LEE, JIN: "Green Tea Catechin-Inactivated Viral Vaccine Platform", FRONTIERS IN MICROBIOLOGY, vol. 8, XP055753387, DOI: 10.3389/fmicb.2017.02469 * |
Also Published As
Publication number | Publication date |
---|---|
KR102429564B1 (ko) | 2022-08-03 |
KR20220027100A (ko) | 2022-03-07 |
WO2020197346A2 (ko) | 2020-10-01 |
KR20200114310A (ko) | 2020-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5319490A (en) | Preventive and curative medicament against infection with influenza virus | |
WO2006113214A3 (en) | Vaccine against pandemic strains of influenza viruses | |
IL154913A0 (en) | Composition comprising immunogenic microparticles | |
WO2007002470A3 (en) | Inactivated chimeric vaccines and related methods of use | |
WO2007112834A3 (de) | Herbizide mittel als dispersionen enthaltend diflufenican und flurtamone | |
WO2007124479A3 (en) | Avian influenza viruses, vaccines, compositions, formulations, and methods | |
WO2006062807A3 (en) | Compositions with enhanced immunogenicity | |
PH12021550484A1 (en) | Immunological adjuvant and vaccine composition including sting agonist | |
WO2022140364A3 (en) | African swine fever (asf) virus vaccines | |
PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
WO2016062020A9 (zh) | 茯苓多糖活性组分和成分、其制备方法及用途 | |
WO2020197346A3 (ko) | 녹차 유래 성분을 함유하는 바이러스 백신용 면역증강제 조성물 | |
WO2006041978A3 (en) | Multivalent avian influenza vaccines | |
MX2019012620A (es) | Composiciones de vacunas. | |
RU2018137684A (ru) | Косметические композиции для защиты от веществ, загрязняющих воздух | |
WO2016200113A3 (ko) | 녹차 추출물에 의해 불화된 바이러스를 포함하는 백신 및 그의 제조방법 | |
WO2013004579A3 (en) | Ethers of bis(hydroxymethyl)cyclohexanes | |
MY196126A (en) | Container-Packed Green Tea Beverage | |
EP3973976A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT OF CAMELLIA JAPONICA AS ACTIVE PRINCIPAL FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTIONS | |
PH12021550233A1 (en) | Low-foam adjuvant combination for formulations for crop protection | |
WO2009071613A3 (en) | Vaccine | |
RU2016152595A (ru) | Сухой оздоровительный напиток | |
Arthur et al. | Irish Republican Army | |
JP2017184719A5 (ko) | ||
WO2002045738A3 (es) | Composicion vacunal que contiene factor de crecimiento transformante alfa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20777885 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20777885 Country of ref document: EP Kind code of ref document: A2 |